OmniAb (OABI) Operating Income (2021 - 2026)
OmniAb (OABI) reported Operating Income of -$7.8 million for Q1 2026, up 58.45% year-over-year from -$4.9 million in Q1 2025, and up 50.34% quarter-over-quarter from -$15.8 million in Q4 2025.
OmniAb (OABI) Operating Income (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Operating Income data on file, last reported at -$7.8 million in Q1 2026.
- Operating Income for Q1 2026 came in at -$7.8 million, up 58.45% year-over-year; the trailing twelve-month figure through Mar 2026 was -$58.0 million (up 18.14% YoY), and the FY2025 annual result was -$69.0 million, up 7.43% from the prior year.
- Operating Income grew to -$7.8 million in Q1 2026 per OABI's latest filing, from -$15.8 million in the prior quarter.
- Over five years, Operating Income peaked at $9.0 million in Q4 2022 and troughed at -$22.6 million in Q1 2024.
- A 5-year average of -$14.6 million and a median of -$16.2 million in 2025 frame the typical range for Operating Income.
- On a YoY basis, Operating Income climbed as much as 125.54% in 2022 and fell as far as 575002.97% in 2022.
- A 5-year view of Operating Income shows it stood at $9.0 million in 2022, then plunged by 334.32% to -$21.2 million in 2023, then climbed by 25.12% to -$15.9 million in 2024, then advanced by 0.72% to -$15.8 million in 2025, then jumped by 50.34% to -$7.8 million in 2026.
- Business Quant data shows OABI's Operating Income at -$7.8 million in Q1 2026, -$15.8 million in Q4 2025, and -$18.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn | -7.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.83 Mn |
| Dec 31, 2025 | -15.77 Mn |
| Sep 30, 2025 | -18.14 Mn |
| Jun 30, 2025 | -16.22 Mn |
| Mar 31, 2025 | -18.84 Mn |
| Dec 31, 2024 | -15.88 Mn |
| Sep 30, 2024 | -19.76 Mn |
| Jun 30, 2024 | -16.31 Mn |
| Mar 31, 2024 | -22.55 Mn |
| Dec 31, 2023 | -21.21 Mn |
| Sep 30, 2023 | -20.32 Mn |
| Jun 30, 2023 | -19.45 Mn |
| Mar 31, 2023 | -8.45 Mn |
| Dec 31, 2022 | 9.05 Mn |
| Sep 30, 2022 | -14.91 Mn |
| Jun 30, 2022 | -12.57 Mn |
| Mar 31, 2022 | -8.22 Mn |
| Dec 31, 2021 | -35.43 Mn |
| Sep 30, 2021 | -170,579.00 |
| Jun 30, 2021 | -2,185.00 |